Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer.
Gupta S, Strohbehn IA, Wang Q, Hanna PE, Seethapathy R, Prosek JM, Herrmann SM, Abudayyeh A, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, de Seigneux S, Campedel L, Kitchlu A, Shin DS, Coppock G, Lumlertgul N, Garcia P, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Benesova K, Jhaveri KD, Cortazar FB, Weins A, Zuo Y, Mooradian MJ, Reynolds KL, Leaf DE, Sise ME; ICPi-AKI Consortium. Gupta S, et al. Among authors: sprangers b. Kidney Int. 2022 Oct;102(4):930-935. doi: 10.1016/j.kint.2022.07.019. Epub 2022 Aug 11. Kidney Int. 2022. PMID: 35964800 Free PMC article. No abstract available.
Xenotransplantation: where are we in 2008?
Sprangers B, Waer M, Billiau AD. Sprangers B, et al. Kidney Int. 2008 Jul;74(1):14-21. doi: 10.1038/ki.2008.135. Epub 2008 Apr 16. Kidney Int. 2008. PMID: 18418354 Free article. Review.
Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
Yazdani S, Callemeyn J, Gazut S, Lerut E, de Loor H, Wevers M, Heylen L, Saison C, Koenig A, Thaunat O, Thorrez L, Kuypers D, Sprangers B, Noël LH, Van Lommel L, Schuit F, Essig M, Gwinner W, Anglicheau D, Marquet P, Naesens M. Yazdani S, et al. Among authors: sprangers b. Kidney Int. 2019 Jan;95(1):188-198. doi: 10.1016/j.kint.2018.08.027. Epub 2018 Nov 3. Kidney Int. 2019. PMID: 30396694 Free article.
Cancer Survivorship.
Sprangers B, Jhaveri KD, Perazella MA. Sprangers B, et al. N Engl J Med. 2019 Apr 4;380(14):1381-1382. doi: 10.1056/NEJMc1900709. N Engl J Med. 2019. PMID: 30943355 No abstract available.
AKI in Patients Receiving Immune Checkpoint Inhibitors.
Perazella MA, Sprangers B. Perazella MA, et al. Among authors: sprangers b. Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1077-1079. doi: 10.2215/CJN.02340219. Epub 2019 May 2. Clin J Am Soc Nephrol. 2019. PMID: 31048326 Free PMC article. No abstract available.
197 results